Newsroom

Newsroom

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Press Release
Read More

Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project

Literature
Read More

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

Press Release
Read More

Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy

Literature
Read More

A comprehensive genomic profiling approach to interrogate hematologic malignancies

Literature
Read More

Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM

Literature
Read More

Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC

Literature
Read More

Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients